Table 3.
Patient baseline characteristics of the additional cohort
| Characteristics | HC (n = 20) (%) | Patient (n = 110) |
||
|---|---|---|---|---|
| CHB (n = 25) (%) | LC (n = 30) (%) | HCC (n = 45) (%) | ||
| Age (year) | ||||
| Mean ± SD | 50.0 ± 14.1 | 46.3 ± 10.9 | 49 ± 10.12 | 54.0 ± 10.0 |
| Sex | ||||
| Male | 14 (70.0) | 15 (60.0) | 18 (60.0) | 28 (62.2) |
| Female | 6 (30.0) | 10 (40.0) | 12 (40.0) | 17 (37.8) |
| HBsAg | ||||
| Yes | \ | 25 (100) | 30 (100) | 45 (100) |
| No | \ | 0 | 0 | 0 |
HBsAg, Hepatitis B surface antigen.